Ebola Drug Shows Signs of Efficacy Among Early Patients in Study
This article is for subscribers only.
An experimental Ebola treatment may have helped some patients survive when used at the early stages of disease in West Africa, researchers said.
Among 80 patients who got the antiviral drug favipiravir, the death rate for those with less-advanced Ebola was 15 percent, compared with 30 percent for less-advanced patients who didn’t get the drug during a three-month period before the trial began.